Takeda Oncology Research Grants
Takeda Oncology Research Grants fund projects advancing research and education in GI, hematologic, and thoracic cancers to improve patient outcomes and scientific understanding.
Funder: Takeda Pharmaceuticals
Due Dates: Rolling (submit at least 60 days before program start date)
Funding Amounts: No set minimum or maximum; amount varies by project scope and request type.
Summary: Supports organizations advancing cancer research, education, and patient care—especially in GI, hematology, and thoracic cancers—through grants, sponsorships, or donations.
Key Information: Applications must be submitted online; funding is available to legally established organizations only.
Description
Takeda Oncology Research Grants provide external funding to support initiatives that align with Takeda Oncology's mission to advance cancer treatment. Funding may be monetary or in-kind and is available for a variety of activities, including independent medical education, scientific or educational conferences, patient support, and general fundraising activities. The program prioritizes research and educational projects in gastrointestinal (metastatic colorectal cancer), hematology (including lymphoma, leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms), and thoracic (lung cancer) diseases. Takeda considers unsolicited requests that address unmet educational or research needs, improve patient outcomes, or promote excellence in patient care.
